Use of Topical or Systemic Steroids in Children with Upper Respiratory Tract Infection

Steroids have long been used to improve a number of clinical conditions because of their role in reducing inflammatory responses, but their use has always been limited because of their possible long-term side effects. The aim of this review is to establish whether steroids can have a positive effect...

Full description

Bibliographic Details
Main Authors: S. Esposito, S. Bianchini, E. Baggi, L. Castellazzi, M. Fumagalli, N. Principi
Format: Article
Language:English
Published: SAGE Publishing 2013-05-01
Series:European Journal of Inflammation
Online Access:https://doi.org/10.1177/1721727X1301100203
id doaj-40d02596c86e463c8fc88f645693d076
record_format Article
spelling doaj-40d02596c86e463c8fc88f645693d0762020-11-25T02:48:08ZengSAGE PublishingEuropean Journal of Inflammation1721-727X2013-05-011110.1177/1721727X1301100203Use of Topical or Systemic Steroids in Children with Upper Respiratory Tract InfectionS. Esposito0S. Bianchini1E. Baggi2L. Castellazzi3M. Fumagalli4N. Principi5 Pediatric Clinic 1, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca‘ Granda Ospedale Maggiore Policlinico, Milan, Italy Pediatric Clinic 1, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca‘ Granda Ospedale Maggiore Policlinico, Milan, Italy Pediatric Clinic 1, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca‘ Granda Ospedale Maggiore Policlinico, Milan, Italy Pediatric Clinic 1, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca‘ Granda Ospedale Maggiore Policlinico, Milan, Italy NICU, Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Fondazione IRCCS Ca‘ Granda Ospedale Maggiore Policlinico, Milan, Italy Pediatric Clinic 1, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca‘ Granda Ospedale Maggiore Policlinico, Milan, ItalySteroids have long been used to improve a number of clinical conditions because of their role in reducing inflammatory responses, but their use has always been limited because of their possible long-term side effects. The aim of this review is to establish whether steroids can have a positive effect on the outcome of some pediatric upper respiratory tract infections. We used PubMed to select all of the studies on topical or systemic steroids, and their therapeutic use in children with rhinosinusitis (RS), acute otitis media (AOM), otitis media with effusion (OME), acute pharyngitis (AP), or periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA), published over the last 15 years. Although a generally significant improvement in signs and symptoms has been observed with the use of intranasal steroids in children with RS, it is not clear which molecule should be recommended, how long treatment should be continued, or whether the benefits are limited to allergic children. No high-quality studies on the use of topical or systemic steroids in AOM have been carried out, and the results of studies of OME are controversial. The potential positive effects of steroids in children with AP are too slight to justify their use, and their possible adverse effects (particularly in the case of repeated administration) have not been clearly evaluated. Oral corticosteroids seem to be effective in resolving the symptoms of PFAPA, although they do not prevent future fever cycles. These findings show that further randomised and controlled studies are required in order to approach upper respiratory tract infections correctly and avoid the risks associated with frequent steroid use.https://doi.org/10.1177/1721727X1301100203
collection DOAJ
language English
format Article
sources DOAJ
author S. Esposito
S. Bianchini
E. Baggi
L. Castellazzi
M. Fumagalli
N. Principi
spellingShingle S. Esposito
S. Bianchini
E. Baggi
L. Castellazzi
M. Fumagalli
N. Principi
Use of Topical or Systemic Steroids in Children with Upper Respiratory Tract Infection
European Journal of Inflammation
author_facet S. Esposito
S. Bianchini
E. Baggi
L. Castellazzi
M. Fumagalli
N. Principi
author_sort S. Esposito
title Use of Topical or Systemic Steroids in Children with Upper Respiratory Tract Infection
title_short Use of Topical or Systemic Steroids in Children with Upper Respiratory Tract Infection
title_full Use of Topical or Systemic Steroids in Children with Upper Respiratory Tract Infection
title_fullStr Use of Topical or Systemic Steroids in Children with Upper Respiratory Tract Infection
title_full_unstemmed Use of Topical or Systemic Steroids in Children with Upper Respiratory Tract Infection
title_sort use of topical or systemic steroids in children with upper respiratory tract infection
publisher SAGE Publishing
series European Journal of Inflammation
issn 1721-727X
publishDate 2013-05-01
description Steroids have long been used to improve a number of clinical conditions because of their role in reducing inflammatory responses, but their use has always been limited because of their possible long-term side effects. The aim of this review is to establish whether steroids can have a positive effect on the outcome of some pediatric upper respiratory tract infections. We used PubMed to select all of the studies on topical or systemic steroids, and their therapeutic use in children with rhinosinusitis (RS), acute otitis media (AOM), otitis media with effusion (OME), acute pharyngitis (AP), or periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA), published over the last 15 years. Although a generally significant improvement in signs and symptoms has been observed with the use of intranasal steroids in children with RS, it is not clear which molecule should be recommended, how long treatment should be continued, or whether the benefits are limited to allergic children. No high-quality studies on the use of topical or systemic steroids in AOM have been carried out, and the results of studies of OME are controversial. The potential positive effects of steroids in children with AP are too slight to justify their use, and their possible adverse effects (particularly in the case of repeated administration) have not been clearly evaluated. Oral corticosteroids seem to be effective in resolving the symptoms of PFAPA, although they do not prevent future fever cycles. These findings show that further randomised and controlled studies are required in order to approach upper respiratory tract infections correctly and avoid the risks associated with frequent steroid use.
url https://doi.org/10.1177/1721727X1301100203
work_keys_str_mv AT sesposito useoftopicalorsystemicsteroidsinchildrenwithupperrespiratorytractinfection
AT sbianchini useoftopicalorsystemicsteroidsinchildrenwithupperrespiratorytractinfection
AT ebaggi useoftopicalorsystemicsteroidsinchildrenwithupperrespiratorytractinfection
AT lcastellazzi useoftopicalorsystemicsteroidsinchildrenwithupperrespiratorytractinfection
AT mfumagalli useoftopicalorsystemicsteroidsinchildrenwithupperrespiratorytractinfection
AT nprincipi useoftopicalorsystemicsteroidsinchildrenwithupperrespiratorytractinfection
_version_ 1724749756007186432